Agios Pharmaceuticals Inc. (AGIO) News Nov 20, 201
Post# of 250663
Posted On: 11/20/2014 7:00:08 PM
Agios Pharmaceuticals Inc. (AGIO) News Nov 20, 2014, 5:35 p.m.
MarketWatch News on AGIO
Growth stocks provide litmus test for stock market 3:13 p.m. Nov. 18, 2014 - The Trading Deck
The double-edged sword of growth-stock speculation 2:30 p.m. Nov. 14, 2014 - The Trading Deck
Two biotech leaders to watch 1:13 p.m. Oct. 28, 2014 - The Trading Deck
6 stocks to watch 2:10 p.m. Oct. 22, 2014 - The Trading Deck
S&P 500 returns to scene of the breakdown 9:56 a.m. Oct. 3, 2014 - Michael Ashbaugh
15 small-cap stocks Goldman Sachs says are worth a look 10:51 a.m. July 22, 2014 - blogs.marketwatch.com
Stock futures drop as earnings season looms 8:20 a.m. April 7, 2014 - Sara Sjolin
Agios shares rally 6.4% premarket after upbeat trial results 6:28 a.m. April 7, 2014 - Sara Sjolin
Other News on AGIO
Agios (AGIO) Shares Up on Positive AG-120 Study Data - Analyst Blog 4:33 p.m. Today - Zacks.com
Agios Pharmaceuticals (AGIO) Showing Signs Of Perilous Reversal Today 9:48 a.m. Today - TheStreet.com
Agios Pharmaceuticals (AGIO) in Focus: Stock Rises 14.5% - Tale of the Tape 8:51 a.m. Today - Zacks.com
Jim Cramer Explains Why Investors Win With Agios Pharmaceuticals (AGIO) 2:11 p.m. Nov. 19, 2014 - TheStreet.com
Cramer: Agios Pharmaceuticals' Leukemia Drug Pushing Stock 'Much Higher' 11:21 a.m. Nov. 19, 2014 - TheStreet.com
Agios leukemia drug candidate shows clinical activity in Phase 1 trial 9:01 a.m. Nov. 19, 2014 - Seeking Alpha
Trade-Ideas: Agios Pharmaceuticals (AGIO) Is Today's Post-Market Leader Stock 6:20 p.m. Nov. 18, 2014 - TheStreet.com
Agios Cancer 'Metabolism' Drug Clears Bone Marrow of Leukemic Cells 6:02 p.m. Nov. 18, 2014 - TheStreet.com
Jim Cramer Says to Buy Six Flags, Avoid SeaWorld Entertainment 2:20 p.m. Nov. 12, 2014 - TheStreet.com
11 Biotechnology Stocks to Buy Now 4:15 a.m. Nov. 12, 2014 - InvestorPlace.com
Biotech Weekly: When Mid Caps Are Priced Nearly For Perfection 10:28 a.m. Nov. 10, 2014 - Seeking Alpha
Agios Pharmaceuticals' (AGIO) CEO David Schenkein on Q3 2014 Results - Earnings Call Transcript 7:31 a.m. Nov. 8, 2014 - Seeking Alpha
Agios Pharmaceuticals (AGIO) Stock: Weak On High Volume Today 10:02 a.m. Nov. 7, 2014 - TheStreet.com
Will Agios (AGIO) Disappoint in the Q3 Earnings Season? - Analyst Blog 5:10 p.m. Nov. 6, 2014 - Zacks.com
Insider Trading Alert - ENTA, CTSH And AGIO Traded By Insiders 11:24 a.m. Nov. 5, 2014 - TheStreet.com
Super Important Biotech and Drug Stock Events for November 8:24 a.m. Nov. 3, 2014 - TheStreet.com
Cramer's Lightning Round - Isis Pharmaceuticals Has The Best Pipeline (10/28/14) 6:59 a.m. Oct. 29, 2014 - Seeking Alpha
'Mad Money' Lightning Round: I'm Sticking With Isis Pharmaceuticals 6:00 a.m. Oct. 29, 2014 - TheStreet.com
Jim Cramer's 'Mad Money' Recap: Winners in the Expectations Game 8:26 p.m. Oct. 28, 2014 - TheStreet.com
Fab Four - Got To Get You Into My Life 1:24 p.m. Oct. 24, 2014 - Seeking Alpha
Press Releases on AGIO
Critical Alerts For Agios Pharmaceuticals, Target, Dollar General, Lululemon and Costco Released By InvestorsObserver 9:31 a.m. Today - PR Newswire - PRF
Agios Pharmaceuticals Announces Early Phase 1 Data Showing Clinical Activity of AG-120 as a Single Agent in Advanced Acute Myeloid Leukemia (AML) 6:01 p.m. Nov. 18, 2014 - GlobeNewswire
Agios Pharmaceuticals Reports Third Quarter 2014 Financial Results 7:01 a.m. Nov. 7, 2014 - GlobeNewswire
Agios Pharmaceuticals to Present Clinical and Preclinical Data at the 2014 American Society of Hematology Annual Meeting 9:09 a.m. Nov. 6, 2014 - GlobeNewswire
Critical Alerts For LinkedIn, Imperva Inc, Norfolk Southern, Halliburton and Agios Pharmaceuticals Released By InvestorsObserver 9:31 a.m. Nov. 3, 2014 - PR Newswire - PRF
Agios Pharmaceuticals to Webcast Conference Call of Third Quarter 2014 Financial Results on November 7, 2014 7:32 a.m. Oct. 27, 2014 - GlobeNewswire
Agios Pharmaceuticals Announces Initiation of a Phase 1/2 Clinical Trial of AG-221 in Patients with Advanced Solid Tumors with an IDH2 Mutation 7:31 a.m. Oct. 21, 2014 - GlobeNewswire
Agios Pharmaceuticals Announces Initiation of Four Expansion Cohorts in Phase 1 Study of AG-221 6:30 a.m. Oct. 15, 2014 - GlobeNewswire
Agios Pharmaceuticals to Webcast R&D Day on October 15, 2014 8:02 a.m. Oct. 6, 2014 - GlobeNewswire
Earnings Release Schedules, Data Presentation, Regulatory Approvals, and Strategic Collaboration - Research Reports on Covidien, Biogen, Amgen, Agios and Baxter 7:55 a.m. Oct. 1, 2014 - PR Newswire - PRF
Critical Alerts For Invensense, Agios Pharmaceuticals, SPDR Gold Trust, Nu Skin Enterprises and Nike Released By InvestorsObserver 8:31 a.m. Sept. 29, 2014 - PR Newswire - PRF
Agios Pharmaceuticals to Present Clinical Data from AG-120 Ongoing Phase 1 Study in Hematologic Malignancies at EORTC-NCI-AACR 2014 6:30 a.m. Sept. 26, 2014 - BusinessWire - BZX
Agios Pharmaceuticals to Present at the 2014 Leerink Partners Rare Disease Roundtable 3:06 p.m. Sept. 23, 2014 - GlobeNewswire
Flagship Ventures Appoints Agricultural Industry Leader Robert Berendes as Venture Partner 8:00 a.m. Aug. 25, 2014 - PR Newswire - PRF
Agios Pharmaceuticals Announces the U.S. FDA Grants Fast Track Designation to AG-221 for Treatment of Patients With Acute Myelogenous Leukemia That Harbor an IDH2 Mutation 7:30 a.m. Aug. 13, 2014 - GlobeNewswire
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Agios Pharmaceuticals, Inc. Regarding Possible Breaches of Fiduciary Duty 12:38 p.m. Aug. 12, 2014 - BusinessWire - BZX
Agios Pharmaceuticals Reports Second Quarter 2014 Financial Results 6:31 a.m. Aug. 7, 2014 - GlobeNewswire
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Agios Pharmaceuticals, Inc. Regarding Possible Breaches of Fiduciary Duty 10:14 a.m. July 31, 2014 - BusinessWire - BZX
Agios Pharmaceuticals to Webcast Conference Call of Second Quarter 2014 Financial Results on August 7, 2014 8:01 a.m. July 28, 2014 - GlobeNewswire
Acquisition Agreements, Rejected Acquisition Tender Offers, Appointment, and Technical Updates - Research Reports on Pfizer, Gentiva, bluebird bio, Agios and AcelRx 7:30 a.m. July 23, 2014 - PR Newswire - PRF
MarketWatch News on AGIO
Growth stocks provide litmus test for stock market 3:13 p.m. Nov. 18, 2014 - The Trading Deck
The double-edged sword of growth-stock speculation 2:30 p.m. Nov. 14, 2014 - The Trading Deck
Two biotech leaders to watch 1:13 p.m. Oct. 28, 2014 - The Trading Deck
6 stocks to watch 2:10 p.m. Oct. 22, 2014 - The Trading Deck
S&P 500 returns to scene of the breakdown 9:56 a.m. Oct. 3, 2014 - Michael Ashbaugh
15 small-cap stocks Goldman Sachs says are worth a look 10:51 a.m. July 22, 2014 - blogs.marketwatch.com
Stock futures drop as earnings season looms 8:20 a.m. April 7, 2014 - Sara Sjolin
Agios shares rally 6.4% premarket after upbeat trial results 6:28 a.m. April 7, 2014 - Sara Sjolin
Other News on AGIO
Agios (AGIO) Shares Up on Positive AG-120 Study Data - Analyst Blog 4:33 p.m. Today - Zacks.com
Agios Pharmaceuticals (AGIO) Showing Signs Of Perilous Reversal Today 9:48 a.m. Today - TheStreet.com
Agios Pharmaceuticals (AGIO) in Focus: Stock Rises 14.5% - Tale of the Tape 8:51 a.m. Today - Zacks.com
Jim Cramer Explains Why Investors Win With Agios Pharmaceuticals (AGIO) 2:11 p.m. Nov. 19, 2014 - TheStreet.com
Cramer: Agios Pharmaceuticals' Leukemia Drug Pushing Stock 'Much Higher' 11:21 a.m. Nov. 19, 2014 - TheStreet.com
Agios leukemia drug candidate shows clinical activity in Phase 1 trial 9:01 a.m. Nov. 19, 2014 - Seeking Alpha
Trade-Ideas: Agios Pharmaceuticals (AGIO) Is Today's Post-Market Leader Stock 6:20 p.m. Nov. 18, 2014 - TheStreet.com
Agios Cancer 'Metabolism' Drug Clears Bone Marrow of Leukemic Cells 6:02 p.m. Nov. 18, 2014 - TheStreet.com
Jim Cramer Says to Buy Six Flags, Avoid SeaWorld Entertainment 2:20 p.m. Nov. 12, 2014 - TheStreet.com
11 Biotechnology Stocks to Buy Now 4:15 a.m. Nov. 12, 2014 - InvestorPlace.com
Biotech Weekly: When Mid Caps Are Priced Nearly For Perfection 10:28 a.m. Nov. 10, 2014 - Seeking Alpha
Agios Pharmaceuticals' (AGIO) CEO David Schenkein on Q3 2014 Results - Earnings Call Transcript 7:31 a.m. Nov. 8, 2014 - Seeking Alpha
Agios Pharmaceuticals (AGIO) Stock: Weak On High Volume Today 10:02 a.m. Nov. 7, 2014 - TheStreet.com
Will Agios (AGIO) Disappoint in the Q3 Earnings Season? - Analyst Blog 5:10 p.m. Nov. 6, 2014 - Zacks.com
Insider Trading Alert - ENTA, CTSH And AGIO Traded By Insiders 11:24 a.m. Nov. 5, 2014 - TheStreet.com
Super Important Biotech and Drug Stock Events for November 8:24 a.m. Nov. 3, 2014 - TheStreet.com
Cramer's Lightning Round - Isis Pharmaceuticals Has The Best Pipeline (10/28/14) 6:59 a.m. Oct. 29, 2014 - Seeking Alpha
'Mad Money' Lightning Round: I'm Sticking With Isis Pharmaceuticals 6:00 a.m. Oct. 29, 2014 - TheStreet.com
Jim Cramer's 'Mad Money' Recap: Winners in the Expectations Game 8:26 p.m. Oct. 28, 2014 - TheStreet.com
Fab Four - Got To Get You Into My Life 1:24 p.m. Oct. 24, 2014 - Seeking Alpha
Press Releases on AGIO
Critical Alerts For Agios Pharmaceuticals, Target, Dollar General, Lululemon and Costco Released By InvestorsObserver 9:31 a.m. Today - PR Newswire - PRF
Agios Pharmaceuticals Announces Early Phase 1 Data Showing Clinical Activity of AG-120 as a Single Agent in Advanced Acute Myeloid Leukemia (AML) 6:01 p.m. Nov. 18, 2014 - GlobeNewswire
Agios Pharmaceuticals Reports Third Quarter 2014 Financial Results 7:01 a.m. Nov. 7, 2014 - GlobeNewswire
Agios Pharmaceuticals to Present Clinical and Preclinical Data at the 2014 American Society of Hematology Annual Meeting 9:09 a.m. Nov. 6, 2014 - GlobeNewswire
Critical Alerts For LinkedIn, Imperva Inc, Norfolk Southern, Halliburton and Agios Pharmaceuticals Released By InvestorsObserver 9:31 a.m. Nov. 3, 2014 - PR Newswire - PRF
Agios Pharmaceuticals to Webcast Conference Call of Third Quarter 2014 Financial Results on November 7, 2014 7:32 a.m. Oct. 27, 2014 - GlobeNewswire
Agios Pharmaceuticals Announces Initiation of a Phase 1/2 Clinical Trial of AG-221 in Patients with Advanced Solid Tumors with an IDH2 Mutation 7:31 a.m. Oct. 21, 2014 - GlobeNewswire
Agios Pharmaceuticals Announces Initiation of Four Expansion Cohorts in Phase 1 Study of AG-221 6:30 a.m. Oct. 15, 2014 - GlobeNewswire
Agios Pharmaceuticals to Webcast R&D Day on October 15, 2014 8:02 a.m. Oct. 6, 2014 - GlobeNewswire
Earnings Release Schedules, Data Presentation, Regulatory Approvals, and Strategic Collaboration - Research Reports on Covidien, Biogen, Amgen, Agios and Baxter 7:55 a.m. Oct. 1, 2014 - PR Newswire - PRF
Critical Alerts For Invensense, Agios Pharmaceuticals, SPDR Gold Trust, Nu Skin Enterprises and Nike Released By InvestorsObserver 8:31 a.m. Sept. 29, 2014 - PR Newswire - PRF
Agios Pharmaceuticals to Present Clinical Data from AG-120 Ongoing Phase 1 Study in Hematologic Malignancies at EORTC-NCI-AACR 2014 6:30 a.m. Sept. 26, 2014 - BusinessWire - BZX
Agios Pharmaceuticals to Present at the 2014 Leerink Partners Rare Disease Roundtable 3:06 p.m. Sept. 23, 2014 - GlobeNewswire
Flagship Ventures Appoints Agricultural Industry Leader Robert Berendes as Venture Partner 8:00 a.m. Aug. 25, 2014 - PR Newswire - PRF
Agios Pharmaceuticals Announces the U.S. FDA Grants Fast Track Designation to AG-221 for Treatment of Patients With Acute Myelogenous Leukemia That Harbor an IDH2 Mutation 7:30 a.m. Aug. 13, 2014 - GlobeNewswire
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Agios Pharmaceuticals, Inc. Regarding Possible Breaches of Fiduciary Duty 12:38 p.m. Aug. 12, 2014 - BusinessWire - BZX
Agios Pharmaceuticals Reports Second Quarter 2014 Financial Results 6:31 a.m. Aug. 7, 2014 - GlobeNewswire
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Agios Pharmaceuticals, Inc. Regarding Possible Breaches of Fiduciary Duty 10:14 a.m. July 31, 2014 - BusinessWire - BZX
Agios Pharmaceuticals to Webcast Conference Call of Second Quarter 2014 Financial Results on August 7, 2014 8:01 a.m. July 28, 2014 - GlobeNewswire
Acquisition Agreements, Rejected Acquisition Tender Offers, Appointment, and Technical Updates - Research Reports on Pfizer, Gentiva, bluebird bio, Agios and AcelRx 7:30 a.m. July 23, 2014 - PR Newswire - PRF
(0)
(0)